I've looked closely at most all testing companies conducting CV19 testing in the US, and hands down OPK/BioReference is "the best of breed" regarding accuracy, 2-day turn around results and least errors in processing.
Additionally, RAD's head-on and outright aggressive 'coast to coast' undertaking of CV19 testing with U.S. Department of Health and Human Services will only continue to drive patrons to RAD stores thereby increasing the volume of sales at these stores.
I can't wait to see 2Q20 earning on 9/28 - should be another blow away on both top & bottom numbers - and should put us over the $25 threshold - and keep us there...!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.